Boston Research & Management’s iShares Core MSCI EAFE ETF IEFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.3M Sell
69,552
-229
-0.3% -$21.4K 1.5% 27
2025
Q4
$6.24M Sell
69,781
-796
-1% -$70.4K 1.44% 26
2025
Q3
$6.16M Buy
70,577
+31
+0% +$2.63K 1.36% 27
2025
Q2
$5.89M Buy
70,546
+1,624
+2% +$129K 1.41% 26
2025
Q1
$5.21M Buy
68,922
+29
+0% +$2.17K 1.29% 33
2024
Q4
$4.84M Buy
68,893
+1,615
+2% +$119K 1.19% 39
2024
Q3
$5.25M Buy
67,278
+935
+1% +$70K 1.23% 38
2024
Q2
$4.82M Buy
66,343
+974
+1% +$71.7K 1.22% 37
2024
Q1
$4.85M Sell
65,369
-1,488
-2% -$106K 1.2% 39
2023
Q4
$4.7M Buy
66,857
+1,607
+2% +$106K 1.25% 37
2023
Q3
$4.2M Buy
65,250
+500
+0.8% +$33.5K 1.24% 37
2023
Q2
$4.37M Sell
64,750
-300
-0.5% -$20.3K 1.24% 38
2023
Q1
$4.35M Buy
65,050
+365
+0.6% +$23.9K 1.3% 36
2022
Q4
$3.99M Buy
64,685
+1,208
+2% +$71.1K 1.23% 38
2022
Q3
$3.34M Sell
63,477
-2,976
-4% -$175K 1.14% 44
2022
Q2
$3.91M Buy
66,453
+2,057
+3% +$132K 1.27% 37
2022
Q1
$4.48M Buy
64,396
+350
+0.5% +$24.8K 1.3% 35
2021
Q4
$4.78M Buy
64,046
+347
+0.5% +$26.1K 1.31% 31
2021
Q3
$4.73M Buy
63,699
+2,294
+4% +$175K 1.41% 29
2021
Q2
$4.6M Buy
61,405
+859
+1% +$64.9K 1.39% 32
2021
Q1
$4.36M Buy
60,546
+1,385
+2% +$99K 1.4% 34
2020
Q4
$4.09M Buy
59,161
+1,953
+3% +$126K 1.42% 35
2020
Q3
$3.45M Buy
57,208
+1,004
+2% +$60.6K 1.35% 34
2020
Q2
$3.21M Buy
56,204
+6,671
+13% +$362K 1.33% 35
2020
Q1
$2.47M Sell
49,533
-11,809
-19% -$703K 1.24% 35
2019
Q4
$4M Buy
61,342
+5,323
+10% +$338K 1.5% 36
2019
Q3
$3.42M Buy
56,019
+3,384
+6% +$204K 1.35% 42
2019
Q2
$3.23M Buy
52,635
+2,539
+5% +$156K 1.31% 42
2019
Q1
$3.04M Buy
50,096
+37
+0.1% +$2.18K 1.27% 40
2018
Q4
$2.75M Sell
50,059
-7,411
-13% -$435K 1.31% 39
2018
Q3
$3.68M Buy
57,470
+7,092
+14% +$452K 1.68% 29
2018
Q2
$3.19M Buy
50,378
+631
+1% +$41.8K 1.57% 31
2018
Q1
$3.28M Buy
49,747
+2,315
+5% +$156K 1.67% 28
2017
Q4
$3.13M Sell
47,432
-873
-2% -$56.9K 1.57% 32
2017
Q3
$3.1M Buy
48,305
+1,135
+2% +$71K 1.58% 34
2017
Q2
$2.87M Buy
47,170
+450
+1% +$27.2K 1.55% 35
2017
Q1
$2.71M Buy
46,720
+2,459
+6% +$138K 1.47% 38
2016
Q4
$2.37M Sell
44,261
-56
-0.1% -$3.01K 1.35% 39
2016
Q3
$2.44M Buy
44,317
+1,024
+2% +$55.3K 1.41% 38
2016
Q2
$2.25M Buy
43,293
+10,884
+34% +$582K 1.36% 37
2016
Q1
$1.72M Buy
32,409
+17,954
+124% +$916K 1.07% 46
2015
Q4
$786K Sell
14,455
-6,260
-30% -$347K 0.49% 62
2015
Q3
$1.09M Buy
20,715
+3,310
+19% +$188K 0.72% 59
2015
Q2
$1.01M Buy
17,405
+290
+2% +$17.6K 0.64% 55
2015
Q1
$1M Buy
17,115
+12,175
+246% +$698K 0.63% 54
2014
Q4
$273K Sell
4,940
-4,220
-46% -$239K 0.17% 89
2014
Q3
$533K Buy
+9,160
New +$556K 0.36% 68

Other funds holding IEFA

Boston Research & Management's IEFA Position: Q1 2026 in Review

Boston Research & Management reduced its iShares Core MSCI EAFE ETF (IEFA) stake by 0.33% in Q1 2026, selling an estimated $21.4K and leaving 69,552 shares worth $6.3M. The position accounts for 1.5% of the portfolio, ranked #27.

Boston Research & Management first reported a position in IEFA in Q3 2014 and has held it in 47 quarters since. 2,398 funds tracked by Wall St. Rank hold IEFA as of Q1 2026.

  • Boston Research & Management held 69,552 shares of iShares Core MSCI EAFE ETF worth $6.3M as of Q1 2026.
  • Boston Research & Management sold 229 iShares Core MSCI EAFE ETF shares in Q1 2026, an estimated $21.4K.
  • iShares Core MSCI EAFE ETF made up 1.5% of Boston Research & Management's portfolio in Q1 2026, its #27 holding.
  • Boston Research & Management first reported a position in iShares Core MSCI EAFE ETF in Q3 2014 and has held it in 47 quarters since.
  • 2,398 funds tracked by Wall St. Rank held iShares Core MSCI EAFE ETF as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.